Home Business Capital Delisting: NGX Place Shares of Glaxo SmithKline on Suspension
Capital

Delisting: NGX Place Shares of Glaxo SmithKline on Suspension

Share
Share

Following the approval of the Scheme of Arrangement between Glaxo SmithKline Consumer Nigeria Plc and holders of its fully paid ordinary shares by the Securities and Exchange Commission and sanctioning of the Scheme of Arrangement by the Federal High Court, trading in the Shares of the Company was suspended on the Nigerian Exchange Limited on Monday, 22 January 2024. 

The suspension was to prevent further trading on the shares of the Company given that the effective date of the scheme of Arrangement was Friday, 19 January 2024, being the day the Court Sanction was filed with the Corporate Affairs Commission and to enable the Registrars to update the register of members for payment of the Scheme consideration and eventual delisting of the Company from the NGX.

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

NGX Group Hosts Katsina State Governor, Strengthens Collaboration On Capital Market Opportunities

Nigerian Exchange Group (NGX Group) hosted the Executive Governor of Katsina State,...

EFCC, NGX RegCo To Strengthen Partnership On Market Integrity

NGX Regulation Limited (NGX RegCo), the independent regulation subsidiary of Nigerian Exchange...

SEC Cautions Nigerians Against Risevest, Stecs Cooperative Societies, Says They Are Not Registered

BY NKECHI NAECHE- ESEZOBOR–The Securities and Exchange Commission (SEC) has warned the...

ASAM Forecasts 39% ASI Growth on Bank Recapitalization, New Listings

The Nigerian stock market is poised for significant growth in 2025, with...